相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Small molecules in targeted cancer therapy: advances, challenges, and future perspectives
Lei Zhong et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)
Japanese version of The Cancer Genome Atlas, JCGA, established using fresh frozen tumors obtained from 5143 cancer patients
Takeshi Nagashima et al.
CANCER SCIENCE (2020)
OPRM1, OPRK1, and COMT genetic polymorphisms associated with opioid effects on experimental pain: a randomized, double-blind, placebo-controlled study
Kwo Wei David Ho et al.
PHARMACOGENOMICS JOURNAL (2020)
Development of therapeutic antibodies for the treatment of diseases
Ruei-Min Lu et al.
JOURNAL OF BIOMEDICAL SCIENCE (2020)
Association between dopamine receptor gene polymorphisms and effects of risperidone treatment: A systematic review and meta-analysis
Lingyue Ma et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2019)
Opioid response in paediatric cancer patients and the Val158Met polymorphism of the human catechol-O-methyltransferase (COMT) gene: an Italian study on 87 cancer children and a systematic review
Ersilia Lucenteforte et al.
BMC CANCER (2019)
Whole exome sequencing detects variants of genes that mediate response to anticancer drugs
Sumiko Ohnami et al.
JOURNAL OF TOXICOLOGICAL SCIENCES (2017)
The Basic Pharmacology of Opioids Informs the Opioid Discourse about Misuse and Abuse: A Review
Joseph V. Pergolizzi et al.
PAIN AND THERAPY (2017)
Human Genetic Variability Contributes to Postoperative Morphine Consumption
Manuela De Gregori et al.
JOURNAL OF PAIN (2016)
Safety and Efficacy of Nivolumab in Patients With Metastatic Renal Cell Carcinoma Treated Beyond Progression A Subgroup Analysis of a Randomized Clinical Trial
Saby George et al.
JAMA ONCOLOGY (2016)
The genetic influences on oxycodone response characteristics in human experimental pain
Anne E. Olesen et al.
FUNDAMENTAL & CLINICAL PHARMACOLOGY (2015)
Novel associations between FAAH genetic variants and postoperative central opioid-related adverse effects
S. Sadhasivam et al.
PHARMACOGENOMICS JOURNAL (2015)
Effects of the Mu Opioid Receptor Polymorphism (OPRM1 A118G) on Pain Regulation, Placebo Effects and Associated Personality Trait Measures
Marta Pecina et al.
NEUROPSYCHOPHARMACOLOGY (2015)
Influence of UGT2B7, OPRM1 and ABCB1 Gene Polymorphisms on Postoperative Morphine Consumption
Salumeh Bastami et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2014)
Implementation of individualized medicine for cancer patients by multiomics-based analyses-the Project HOPE-
Ken Yamaguchi et al.
BIOMEDICAL RESEARCH-TOKYO (2014)
Gene Polymorphisms of OPRM1 A118G and ABCB1 C3435T May Influence Opioid Requirements in Chinese Patients with Cancer Pain
Xiao-Di Gong et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2013)
Pharmacogenetics of pain and analgesia
M. T. Smith et al.
CLINICAL GENETICS (2012)
Basic opioid pharmacology: an update
Hasan Pathan et al.
BRITISH JOURNAL OF PAIN (2012)
Pharmacological Consequence of the A118G μ Opioid Receptor Polymorphism on Morphine- and Fentanyl-mediated Modulation of Ca2+ Channels in Humanized Mouse Sensory Neurons
Saifeldin Mahmoud et al.
ANESTHESIOLOGY (2011)
A KCNJ6 (Kir3.2, GIRK2) gene polymorphism modulates opioid effects on analgesia and addiction but not on pupil size
Joern Loetsch et al.
PHARMACOGENETICS AND GENOMICS (2010)
Anxiety, depression, and pain: differences by primary cancer
Dena J. Fischer et al.
SUPPORTIVE CARE IN CANCER (2010)
Association of ABCB1/MDR1 and OPRM1 gene polymorphisms with morphine pain relief
D. Campa et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
Environmental and genetic factors associated with morphine response in the postoperative period
L Coulbault et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2006)
Opioids in renal failure and dialysis patients
M Dean
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2004)
Morphine and alternative opioids in cancer pain: the EAPC recommendations
GW Hanks et al.
BRITISH JOURNAL OF CANCER (2001)